Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

The association of dipeptidyl peptidase IV inhibitors and other risk factors with bullous pemphigoid in patients with type 2 diabetes mellitus: A retrospective cohort study.

Guo JY, Chen HH, Yang YC, Wu PY, Chang MP, Chen CC.

J Diabetes Complications. 2020 Mar;34(3):107515. doi: 10.1016/j.jdiacomp.2019.107515. Epub 2019 Dec 28.

PMID:
31932172
2.

Effect of mean HbA1c on the association of HbA1c variability and all-cause mortality in patients with type 2 diabetes.

Tseng JY, Chen HH, Huang KC, Hsu SP, Chen CC.

Diabetes Obes Metab. 2020 Jan 5. doi: 10.1111/dom.13951. [Epub ahead of print]

PMID:
31903705
3.

Genetic risk score for risk prediction of diabetic nephropathy in Han Chinese type 2 diabetes patients.

Liao LN, Li TC, Li CI, Liu CS, Lin WY, Lin CH, Yang CW, Chen CC, Chang CT, Yang YF, Liu YL, Kuo HL, Tsai FJ, Lin CC.

Sci Rep. 2019 Dec 27;9(1):19897. doi: 10.1038/s41598-019-56400-3.

4.

C-Reactive Protein Gene Variants and Their Serum Levels in Early Adult-onset Type 2 Diabetes Mellitus.

Huang YC, Chen CC, Wang TY, Nguyen HTT, Chen YH, Wu CM, Chang YW, Liao WL, Tsai FJ.

In Vivo. 2019 Sep-Oct;33(5):1685-1690. doi: 10.21873/invivo.11656.

5.

Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review.

Hirose T, Chen CC, Ahn KJ, Kiljański J.

Diabetes Ther. 2019 Jun;10(3):805-833. doi: 10.1007/s13300-019-0613-7. Epub 2019 Apr 24. Review.

6.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
7.

Effect of adiponectin level and genetic variation of its receptors on diabetic retinopathy: A case-control study.

Liao WL, Chen YH, Chen CC, Huang YC, Lin HJ, Chen YT, Ban B, Wu CM, Chang YW, Hsieh AR, Tsai FJ.

Medicine (Baltimore). 2019 Mar;98(11):e14878. doi: 10.1097/MD.0000000000014878.

8.

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment.

Tien KJ, Hung YJ, Chen JF, Chen CC, Wang CY, Hwu CM, Huang YY, Hsiao PJ, Tu ST, Wang CH, Sheu WH.

J Diabetes Investig. 2019 May;10(3):560-570. doi: 10.1111/jdi.12984. Epub 2019 Jan 18. Review.

9.

Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients.

Liao WL, Chang CT, Chen CC, Lee WJ, Lin SY, Liao HY, Wu CM, Chang YW, Chen CJ, Tsai FJ.

J Clin Med. 2018 Nov 26;7(12). pii: E483. doi: 10.3390/jcm7120483.

10.

High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with ARHGAP22 expression.

Huang YC, Liao WL, Lin JM, Chen CC, Liu SP, Chen SY, Lin YN, Lei YJ, Liu HT, Chen YJ, Tsai FJ.

Oncotarget. 2018 Apr 3;9(25):17858-17866. doi: 10.18632/oncotarget.24909. eCollection 2018 Apr 3.

11.

Study design and recruitment for a prospective controlled study of diabesity: Taiwan Diabesity Study.

Lee WJ, Chang YC, Almalki O, Chao SH, Lu CH, Chen CC, Huang YY, Lee YC, Hsu CC.

Asian J Surg. 2019 Jan;42(1):244-250. doi: 10.1016/j.asjsur.2018.02.007. Epub 2018 Apr 6.

12.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group.

N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.

13.

Levels of high-mobility group box-1 in gingival crevicular fluid in nonsmokers and smokers with chronic periodontitis.

Lin YC, Wu CY, Chang LY, Chen CC, Chen HH, Lai YL, Hung SL.

J Formos Med Assoc. 2017 Dec;116(12):933-939. doi: 10.1016/j.jfma.2017.01.006. Epub 2017 Feb 13.

14.

Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes.

Liao WL, Lee WJ, Chen CC, Lu CH, Chen CH, Chou YC, Lee IT, Sheu WH, Wu JY, Yang CF, Wang CH, Tsai FJ.

Oncotarget. 2017 Mar 14;8(11):18050-18058. doi: 10.18632/oncotarget.14951.

15.

KCNQ1 variants associate with hypertension in type 2 diabetes and affect smooth muscle contractility in vitro.

Huang KC, Li TM, Liu X, Chen JH, Chien WK, Shiao YT, Tsang H, Lin TH, Liao CC, Huang SM, Li JP, Lin CW, Lin JC, Lin CC, Lai CH, Cheng CF, Liang WM, Hung CH, Chen CC, Lin YJ, Tsai FJ.

J Cell Physiol. 2017 Dec;232(12):3309-3316. doi: 10.1002/jcp.25775. Epub 2017 Apr 10.

PMID:
28059450
16.

Andrographolide inhibits adipogenesis of 3T3-L1 cells by suppressing C/EBPβ expression and activation.

Chen CC, Chuang WT, Lin AH, Tsai CW, Huang CS, Chen YT, Chen HW, Lii CK.

Toxicol Appl Pharmacol. 2016 Sep 15;307:115-122. doi: 10.1016/j.taap.2016.07.021. Epub 2016 Jul 27.

PMID:
27475717
17.

Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study.

Hung YC, Lin CC, Huang WL, Chang MP, Chen CC.

Sci Rep. 2016 Jul 27;6:30499. doi: 10.1038/srep30499.

18.

Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine.

Huang KC, Huang HJ, Chen CC, Chang CT, Wang TY, Chen RH, Chen YC, Tsai FJ.

BMC Complement Altern Med. 2015 Jul 14;15:229. doi: 10.1186/s12906-015-0761-x.

19.

Glycemic control paradox: Poor glycemic control associated with higher one-year and eight-year risks of all-cause hospitalization but lower one-year risk of hypoglycemia in patients with type 2 diabetes.

Li TC, Kardia SL, Li CI, Chen CC, Liu CS, Yang SY, Muo CS, Peyser PA, Lin CC.

Metabolism. 2015 Sep;64(9):1013-21. doi: 10.1016/j.metabol.2015.05.004. Epub 2015 May 10.

PMID:
26026367
20.

Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study.

Li CI, Liu CS, Lin WY, Meng NH, Chen CC, Yang SY, Chen HJ, Lin CC, Li TC.

J Bone Miner Res. 2015 Jul;30(7):1338-46. doi: 10.1002/jbmr.2462.

Supplemental Content

Loading ...
Support Center